MGH Researchers Develop AI Tool to Predict Melanoma Recurrence

A team of scientists at Massachusetts General Hospital has developed a new tool that uses AI to predict which patients are most likely to experience a recurrence of melanoma. Read the blog to learn how this research may lead to more effective treatment for patients in the early stages of melanoma.

Read More...

Comments

Popular posts from this blog

Understanding the Drivers and Benefits of Edge Computing